Originally published May 20.

NEW YORK (GenomeWeb) – The US National Institutes of Health's Genetic Testing Registry officially expanded its scope this spring from listing diagnostics that gauge germline mutations associated with inherited diseases and pharmacogenetic tests to including assays that gauge somatic gene markers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.